Emerging Markets
- Emerging Markets
J&J’s Rybrevant Takes Lead in Lung Cancer Treatment Landscape...
Published March 5, 2024 The landscape of lung cancer treatment is evolving rapidly, with Johnson & Johnson’s Rybrevant at the forefront of groundbreaking advancements.…
- Emerging Markets
USPTO Considers Changing Terminal Disclaimer Practice to Require Agreement Regarding...
USPTO Considers Changing Terminal Disclaimer Practice to Require Agreement Regarding Enforceability By: Jeffrey W. Schmidt Ph.D. and Karen G Potter Ph.D. On May 10,…
- Emerging Markets
When Your Life Sciences Are on the Line: Protecting Your...
When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets MoFo partners Kate Driscoll and Nate Mendell launched…
- Emerging Markets
Non-Lab Diagnostics: FDA Regulatory Considerations...
Non-Lab Diagnostics: FDA Regulatory Considerations FDA REGULATORY ISSUES[1] The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation…
- Emerging Markets
USPTO Issues Reminder to Examiners on Proper “Means-Plus-Function” Analysis...
On March 18, 2024, the USPTO issued a memorandum to its Examiners reminding them of the resources and proper analysis for interpreting limitations under…
- Emerging Markets
At-Home Diagnostics Articles: Non-Lab Diagnostics: Supply, Manufacturing, and Distribution Agreements...
At-Home Diagnostics Articles: Non-Lab Diagnostics: Supply, Manufacturing, and Distribution Agreements DEVELOPMENT/SUPPLY/MANUFACTURING/DISTRIBUTION ISSUES[1] The advent of the COVID-19 rapid antigen test launched at-home diagnostics to…
- Emerging Markets
Non-Lab Diagnostics: Consumer and User Agreements...
Non-Lab Diagnostics: Consumer and User Agreements CONSUMER/USER ISSUES[1] The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation…